Tempest Therapeutics
Soyoung Han is a seasoned clinical operations professional with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as Sr. Director of Clinical Operations at Tempest Therapeutics since June 2024, Soyoung has previously held similar senior roles, including Sr. Director of Clinical Operations at Summit Therapeutics, Inc. from June 2023 to June 2024, and Associate VP of Clinical Operations at Omeros Corporation for eight years (June 2015 - June 2023). Additional leadership experience includes Director of Clinical Trial Management at Cerevast and Sr. Clinical Research Monitor/Protocol Excellence Lead at Covidien (Medtronic Minimally Invasive Therapies Group). Soyoung Han holds a Master of Science in Nursing from the University of Minnesota, which was earned in January 1995.
This person is not in any teams
This person is not in any offices
Tempest Therapeutics
Tempest Therapeutics is a clinical-stage biotechnology company advancing small molecule therapeutics that modulate anti-tumor immunity pathways.